Search hospitals > Kansas > Kansas City

University of Kansas Medical Center

Claim this profile
Kansas City, Kansas 66103
Global Leader in Parkinson's Disease
Global Leader in Breast Cancer
Conducts research for Heart Failure
Conducts research for Cystic Fibrosis
Conducts research for Stroke
1261 reported clinical trials
88 medical researchers
Photo of University of Kansas Medical Center in Kansas CityPhoto of University of Kansas Medical Center in Kansas CityPhoto of University of Kansas Medical Center in Kansas City

Summary

University of Kansas Medical Center is a medical facility located in Kansas City, Kansas. This center is recognized for care of Parkinson's Disease, Breast Cancer, Heart Failure, Cystic Fibrosis, Stroke and other specialties. University of Kansas Medical Center is involved with conducting 1,261 clinical trials across 1,262 conditions. There are 88 research doctors associated with this hospital, such as Dhanunjaya Lakkireddy, Jeffrey Statland, Andrea D. Jewell, and Rajesh Pahwa.

Area of expertise

1Parkinson's Disease
Global Leader
University of Kansas Medical Center has run 57 trials for Parkinson's Disease. Some of their research focus areas include:
Stage II
Stage I
Stage III
2Breast Cancer
Global Leader
University of Kansas Medical Center has run 48 trials for Breast Cancer. Some of their research focus areas include:
Stage III
HER2 positive
Stage IV

Top PIs

Clinical Trials running at University of Kansas Medical Center

Stroke
Cystic Fibrosis
Multiple Sclerosis
High Blood Pressure
Smoking Cessation
Prostate Cancer
Heart Failure
Lung Cancer
Idiopathic Pulmonary Fibrosis
Multiple Myeloma
Image of trial facility.

Thrombectomy + Angioplasty/Stenting

for Stroke

This trial tests if using a stent to open a blocked neck artery along with removing a brain clot is better than just removing the clot alone for stroke patients with severe artery blockages.
Recruiting2 awards Phase 312 criteria
Image of trial facility.

HeartMate 3 Device

for Heart Failure

Durable left ventricular assist devices (dLVAD) have been increasingly utilized since the mid to late 1990s, with an uptick of utility starting in 2010 following expanded indications for therapy to not only include a bridge to transplantation strategy, but also for those individuals who suffer from advanced heart failure (HF) and do not qualify for cardiac transplantation. Despite the decreasing size of the newest generation devices leading to a lessened occurrence of adverse events, bleeding and infection still remain a concern for clinicians, as well as a general lack of predictability towards adverse events in individuals with a dLVAD in place. There is a lack of description in the literature currently, regarding the interface between what the pump data provides and what is seen in clinical practice. There also is little known about the effects of what is provided in the pump data, in correlation to quality-of-life following dLVAD implantation. Therefore, the purpose of this study is to prospectively analyze normal and abnormal pump data through pump operations such as suction events, low flow alarms as well as other adventitious alarms, PI events and power cable disconnects greater than 20 seconds, from the HeartMate 3 ® dLVAD in order to clinically correlate this data to quality of life, frailty and other various medical conditions and adverse events as defined by the Interagency Registry for Mechanically Assisted Circulatory Support (Intermacs). This will be achieved through two aims: 1) Evaluate the effectiveness of dLVAD pump operations data on clinical practice application (quality of life, frailty and various medical conditions, and adverse events such as GIB, RHF, infection, hypertension, arrhythmias and stroke); and 2) Evaluate correlations and relationships of longitudinal normal and abnormal dLVAD pump operations data, to demographic and clinical variables. This study is the first study to evaluate HeartMate 3 ® dLVAD pump operations data over time for effectiveness in the clinical practice.
Recruiting1 award N/A2 criteria
Image of trial facility.

Surgical Procedures

for Stroke

This international multi-center registry is used to collect existing information and outcomes for patients undergoing an operation for treatment of injuries to the brain including the blockage of blood flow to an area of the brain, an abnormal ballooning of an artery, abnormal tangling of blood vessels, abnormal formation of blood vessels, tearing of vein, and bleeding in the brain. This information is used to help predict outcomes that undergo an operation for treatment of the above-listed brain injuries. Additionally, the information is used to compare techniques and devices' effects on technical and clinical outcomes.
Recruiting1 award N/A2 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at University of Kansas Medical Center?
Where is University of Kansas Medical Center located?
Who should I call to ask about financial aid or insurance network?
What insurance does University of Kansas Medical Center accept?
What awards or recognition has University of Kansas Medical Center received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security